September 15, 2025

New Insights into Duodenal Neuroendocrine Tumor Profiles

Researchers identify expanded hormone and transcription factor profiles in duodenal neuroendocrine tumors.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 09, 2025

Dietary Nitrate Lowers Blood Pressure in Older Adults, Study

Researchers show nitrate-rich beetroot reshapes the oral microbiome.

Conexiant

September 09, 2025

Gastrointestinal Disorders Linked to Sleep Problems

Study of more than 10,000 US adults finds depression accounts for 21% of the relationship between stomach illness and sleep disturbances, suggesting need for integrated treatment approaches

Conexiant

September 08, 2025

FDA Expands Indications for Von Willebrand Disease

FDA expands Vonvendi to adult routine prophylaxis (types 1 and 2) and pediatric on-demand/perioperative use.

Conexiant

September 03, 2025

H Pylori Screening After MI Shows No Bleeding Benefit

Routine testing in hospitalized patients with myocardial infarction produced similar clinical outcomes.

Conexiant

September 03, 2025

Study Maps Delta-Like Protein 3 and SEZ6 Across Tumor Types

Researchers highlight distinct Delta-like protein 3 and seizure-related 6 homolog patterns in neuroendocrine tumors.

Conexiant

September 02, 2025

Robotic Surgery May Improve Emergency Colectomy Outcomes

Expanding robotic surgery in urgent settings.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant